![]() |
Name |
muyocopronol C
|
Molecular Formula | C32H56O6 | |
IUPAC Name* |
18-ethyl-3,7,11,15-tetrahydroxy-2,6,8,10,12,14,16,20-octamethyldocosa-4,8,12,16-tetraenoicacid
|
|
SMILES |
CCC(C)CC(C=C(C)C(O)C(C)C=C(C)C(O)C(C)C=C(C)C(O)C(C)C=CC(O)C(C)C(=O)O)CC
|
|
InChI |
InChI=1S/C32H56O6/c1-11-19(3)15-27(12-2)18-25(9)31(36)24(8)17-23(7)30(35)22(6)16-21(5)29(34)20(4)13-14-28(33)26(10)32(37)38/h13-14,16-20,22,24,26-31,33-36H,11-12,15H2,1-10H3,(H,37,38)/b14-13+,21-16+,23-17+,25-18+/t19?,20-,22-,24-,26+,27?,28+,29-,30-,31-/m0/s1
|
|
InChIKey |
LNNKNTWIMAGYSQ-RTJPJALOSA-N
|
|
Synonyms |
NA
|
|
CAS | NA | |
PubChem CID | NA | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 536.79 | ALogp: | 5.9 |
HBD: | 5 | HBA: | 5 |
Rotatable Bonds: | 17 | Lipinski's rule of five: | Rejected |
Polar Surface Area: | 118.2 | Aromatic Rings: | 0 |
Heavy Atoms: | 38 | QED Weighted: | 0.146 |
Caco-2 Permeability: | -4.926 | MDCK Permeability: | 0.00000905 |
Pgp-inhibitor: | 0.002 | Pgp-substrate: | 0.992 |
Human Intestinal Absorption (HIA): | 0.842 | 20% Bioavailability (F20%): | 0.022 |
30% Bioavailability (F30%): | 0.43 |
Blood-Brain-Barrier Penetration (BBB): | 0.345 | Plasma Protein Binding (PPB): | 90.46% |
Volume Distribution (VD): | 0.794 | Fu: | 2.88% |
CYP1A2-inhibitor: | 0.019 | CYP1A2-substrate: | 0.286 |
CYP2C19-inhibitor: | 0.003 | CYP2C19-substrate: | 0.884 |
CYP2C9-inhibitor: | 0.009 | CYP2C9-substrate: | 0.946 |
CYP2D6-inhibitor: | 0.002 | CYP2D6-substrate: | 0.117 |
CYP3A4-inhibitor: | 0.063 | CYP3A4-substrate: | 0.215 |
Clearance (CL): | 4.763 | Half-life (T1/2): | 0.106 |
hERG Blockers: | 0.009 | Human Hepatotoxicity (H-HT): | 0.049 |
Drug-inuced Liver Injury (DILI): | 0.963 | AMES Toxicity: | 0.003 |
Rat Oral Acute Toxicity: | 0.083 | Maximum Recommended Daily Dose: | 0.007 |
Skin Sensitization: | 0.005 | Carcinogencity: | 0.01 |
Eye Corrosion: | 0.003 | Eye Irritation: | 0.007 |
Respiratory Toxicity: | 0.018 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC005724 | ![]() |
0.718 | D02KFP | ![]() |
0.188 | ||
ENC005723 | ![]() |
0.571 | D0B8SY | ![]() |
0.185 | ||
ENC005021 | ![]() |
0.380 | D03KIA | ![]() |
0.184 | ||
ENC004454 | ![]() |
0.314 | D0N3NO | ![]() |
0.162 | ||
ENC005126 | ![]() |
0.282 | D03SVX | ![]() |
0.161 | ||
ENC002304 | ![]() |
0.269 | D0VM8K | ![]() |
0.158 | ||
ENC005670 | ![]() |
0.244 | D09XWD | ![]() |
0.156 | ||
ENC005668 | ![]() |
0.243 | D02RQU | ![]() |
0.155 | ||
ENC005666 | ![]() |
0.243 | D0RA5Q | ![]() |
0.154 | ||
ENC002712 | ![]() |
0.240 | D06HZY | ![]() |
0.153 |